US$ 21.04
bpc 157 multiple sclerosis clinical trial humans trials in Multifunctionality and Possible Medical Application
Description
Dealing with Persistent Flushing Comprehensive Flushing Protocol: Week 1: Reduce BPC-157 to 200 mcg once daily Inject at bedtime Take 10 mg cetirizine (Zyrtec) 30 minutes before injection Ensure well hydrated (64+ oz water daily) Week 2: If flushing resolved, maintain current protocol If persisting, drop to 150 mcg daily Add 500 mg niacinamide (not niacin) daily to support vascular stability Week 3: If still flushing, switch to intramuscular administration Consider alternating days instead of daily Evaluate peptide source quality Week 4+: If flushing still problematic, discontinue and try TB-500 instead Or switch to topical BPC-157 formulations for localized applications Addressing Injection Site Issues Nodule Resolution Protocol: For persistent subcutaneous lumps: Stop injecting affected area completely for 2 to 4 weeks Gentle massage 2 to 3 times daily with moisturizer or oil Warm compress 10 to 15 minutes twice daily Topical DMSO (dimethyl sulfoxide) may help dissolve deposits (research controversial) Evaluate technique and adjust depth, speed, volume Consider IM administration to avoid subcutaneous depot formation If nodules persist beyond 4 weeks, grow, become painful, or show infection signs, seek medical evaluation

HUBERMAN: This is one reason why babies and kids and teenagers sleep so much is there's a lot of growth hormone release and we tend to grow, that is the tissues and limbs of our body tend to grow during sleep
00027-9/asset/e1d209e9-b5ee-49b1-9514-e6ec0587aacf/main.assets/gr1_lrg.jpg)
It enters the interstitial fluid and is then absorbed into the bloodstream, achieving high bioavailability

They would find the TIP peptide directly counteracts those negative changes
